Abstract
Abstract
Purpose
To report perioperative and long-term postoperative outcomes of cystectomy patients with ileal conduit (IC) urinary diversion undergoing parastomal hernia (PSH) repair.
Method
We reviewed patients who underwent cystectomy and IC diversion between 2003 and 2022 in our center. Baseline variables, including surgical approach of PSH repair and repair technique, were captured. Multivariable Cox regressionanalysis was performed to test for the associations between different variables and PSH recurrence.
Results
Thirty-six patients with a median (IQR) age of 79 (73–82) years were included. The median time between cystectomy and PSH repair was 30 (14–49) months. Most PSH repairs (32/36, 89%) were performed electively, while 4 were due to small bowel obstruction. Hernia repairs were performed through open (n=25), robotic (10), and laparoscopic approaches (1). Surgical techniques included direct repair with mesh (20), direct repair without mesh (4), stoma relocation with mesh (5), and stomarelocation without mesh (7). The 90-day complication rate was 28%. In a median follow-up of 24 (7–47) months, 17 patients (47%) had a recurrence. The median time to recurrence was 9 (7–24) months. On multivariable analysis, 90-day complication following PSH repair was associated with an increased risk of recurrence.
Conclusions
In this report of one of the largest series of PSH repair in the Urology literature, 47% of patients had a recurrence following hernia repair with a median follow-up time of 2 years. There was no significant difference in recurrence rates when comparing repair technique or the use of open or minimally invasive approaches.
Funder
University of Southern California
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Richters A, Aben KKH, Kiemeney L (2020) The global burden of urinary bladder cancer: an update. World J Urol Aug 38(8):1895–1904. https://doi.org/10.1007/s00345-019-02984-4
2. Chang SS, Bochner BH, Chou R et al (2017) Treatment of non-metastatic muscle-invasive bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline. J Urol Sep 198(3):552–559. https://doi.org/10.1016/j.juro.2017.04.086
3. Lee RK, Abol-Enein H, Artibani W et al (2014) Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes. BJU Int Jan 113(1):11–23. https://doi.org/10.1111/bju.12121
4. Lin-Brande M, Nazemi A, Pearce SM et al (2019) Assessing trends in urinary diversion after radical cystectomy for bladder cancer in the United States. Urol Oncol Mar 37(3):180e. 1-180.e9
5. Lenis AT, Lec PM, Chamie K, Urinary Diversion (2020) JAMA 324(21):2222. https://doi.org/10.1001/jama.2020.17604